Chung Shiu-Dong, Lin Ching-Chun, Wang Li-Hsuan, Lin Herng-Ching, Kang Jiunn-Horng
Division of Urology, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan ; Sleep Research Center, Taipei Medical University Hospital, Taipei, Taiwan.
PLoS One. 2013 Jun 27;8(6):e67459. doi: 10.1371/journal.pone.0067459. Print 2013.
While an association between zolpidem use and fracture and road accident was previously proposed, this study aimed to further explore the frequency and risk of a wide spectrum of injuries in subjects prescribed with zolpidem in Taiwan.
We identified 77,036 subjects who received Zolpidem treatment between 2005 and 2007. We randomly selected 77,036 comparison subjects who were frequency-matched based-on their demographic profiles. We individually tracked each subject for a 90-day period to identify those who subsequently suffered an injury. Cox proportional hazards regressions were performed to calculate the hazard ratio of injury between the two groups.
The incidence rate of injury during the 90-day follow-up period for the total subjects was 18.11 (95% CI = 17.69-18.54) per 100 person-years; this was 24.35 (95% CI = 23.66-25.05) and 11.86 (95% CI = 11.39-12.36) for the study and comparison cohort, respectively. After adjusting for demographic variables, the hazard ratio (HR) of injury during the 90-day follow-up period for study subjects was 1.83 (95% CI = 1.73-1.94) that of comparison subjects. Additionally, compared to comparison subjects, the adjusted HR of injury during the 90-day follow-up period for study subjects who were prescribed Zolpidem for >30 days was as high as 2.17 (95% CI = 2.05-2.32). The adjusted HR of injury to blood vessels for study subjects was particularly high when compared to comparison subjects (HR = 6.34; 95% CI = 1.37-29.38).
We found that patients prescribed with Zolpidem were at a higher risk for a wide range of injuries.
虽然之前有人提出使用唑吡坦与骨折及道路事故之间存在关联,但本研究旨在进一步探究台湾地区服用唑吡坦的受试者发生广泛损伤的频率及风险。
我们确定了2005年至2007年间接受唑吡坦治疗的77036名受试者。我们根据人口统计学特征进行频率匹配,随机选取了77036名对照受试者。我们对每个受试者进行为期90天的个体跟踪,以确定随后受伤的人员。采用Cox比例风险回归分析来计算两组之间受伤的风险比。
在90天随访期内,全部受试者的损伤发生率为每100人年18.11例(95%置信区间=17.69-18.54);研究队列和对照队列的发生率分别为每100人年24.35例(95%置信区间=23.66-25.05)和每100人年11.86例(95%置信区间=11.39-12.36)。在对人口统计学变量进行调整后,研究受试者在90天随访期内受伤的风险比(HR)是对照受试者的1.83倍(95%置信区间=1.73-1.94)。此外,与对照受试者相比,服用唑吡坦超过30天的研究受试者在90天随访期内受伤的调整后HR高达2.17(95%置信区间=2.05-2.32)。与对照受试者相比,研究受试者血管损伤的调整后HR特别高(HR=6.34;95%置信区间=1.37-29.38)。
我们发现服用唑吡坦的患者发生广泛损伤的风险更高。